Literature DB >> 34070665

IgA Vasculitis and IgA Nephropathy: Same Disease?

Evangeline Pillebout1,2.   

Abstract

Many authors suggested that IgA Vasculitis (IgAV) and IgA Nephropathy (IgAN) would be two clinical manifestations of the same disease; in particular, that IgAV would be the systemic form of the IgAN. A limited number of studies have included sufficient children or adults with IgAN or IgAV (with or without nephropathy) and followed long enough to conclude on differences or similarities in terms of clinical, biological or histological presentation, physiopathology, genetics or prognosis. All therapeutic trials available on IgAN excluded patients with vasculitis. IgAV and IgAN could represent different extremities of a continuous spectrum of the same disease. Due to skin rash, patients with IgAV are diagnosed precociously. Conversely, because of the absence of any clinical signs, a renal biopsy is practiced for patients with an IgAN to confirm nephropathy at any time of the evolution of the disease, which could explain the frequent chronic lesions at diagnosis. Nevertheless, the question that remains unsolved is why do patients with IgAN not have skin lesions and some patients with IgAV not have nephropathy? Larger clinical studies are needed, including both diseases, with a common histological classification, and stratified on age and genetic background to assess renal prognosis and therapeutic strategies.

Entities:  

Keywords:  IgA Nephropathy; IgA Vasculitis; adults; children; genetics; physiopathology; presentation; prognosis; treatment

Year:  2021        PMID: 34070665     DOI: 10.3390/jcm10112310

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  89 in total

1.  IgA Cutaneous Purpura Post-Renal Transplantation in a Patient With Long-Standing IgA Nephropathy: Case Report and Literature Review.

Authors:  Bahman Sotoodian; Janet Robert; Muhammad N Mahmood; Elaine Yacyshyn
Journal:  J Cutan Med Surg       Date:  2015-04-15       Impact factor: 2.092

Review 2.  Pathophysiology and treatment of IgA nephropathy in children.

Authors:  N Yoshikawa; R Tanaka; K Iijima
Journal:  Pediatr Nephrol       Date:  2001-05       Impact factor: 3.714

3.  Nationwide epidemiological survey of childhood IgA vasculitis associated hospitalization in the USA.

Authors:  Yusuke Okubo; Kotaro Nochioka; Hiroshi Sakakibara; Hiroshi Hataya; Toshiro Terakawa; Marcia Testa; Robert P Sundel
Journal:  Clin Rheumatol       Date:  2016-09-05       Impact factor: 2.980

4.  A nationwide survey on epidemiological characteristics of childhood Henoch-Schönlein purpura in Taiwan.

Authors:  Y-H Yang; C-F Hung; C-R Hsu; L-C Wang; Y-H Chuang; Y-T Lin; B-L Chiang
Journal:  Rheumatology (Oxford)       Date:  2005-01-25       Impact factor: 7.580

5.  Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis.

Authors:  Krzysztof Kiryluk; Zina Moldoveanu; John T Sanders; T Matthew Eison; Hitoshi Suzuki; Bruce A Julian; Jan Novak; Ali G Gharavi; Robert J Wyatt
Journal:  Kidney Int       Date:  2011-02-16       Impact factor: 10.612

6.  IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.

Authors:  Rosanna Coppo; Licia Peruzzi; Alessandro Amore; Antonio Piccoli; Pierre Cochat; Rosario Stone; Martin Kirschstein; Tommy Linné
Journal:  J Am Soc Nephrol       Date:  2007-05-18       Impact factor: 10.121

Review 7.  Pathogenesis and treatment of ANCA-associated vasculitides.

Authors:  Cees G M Kallenberg
Journal:  Clin Exp Rheumatol       Date:  2015-10-12       Impact factor: 4.473

8.  Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Jürgen Floege; Sean J Barbour; Daniel C Cattran; Jonathan J Hogan; Patrick H Nachman; Sydney C W Tang; Jack F M Wetzels; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Brad H Rovin
Journal:  Kidney Int       Date:  2019-02       Impact factor: 10.612

9.  A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.

Authors:  Motonori Sugiyama; Yukihiro Wada; Nobuhiro Kanazawa; Shohei Tachibana; Taihei Suzuki; Kei Matsumoto; Masayuki Iyoda; Hirokazu Honda; Takanori Shibata
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

10.  Biomarkers of IgA vasculitis nephritis in children.

Authors:  Evangeline Pillebout; Agnès Jamin; Hamza Ayari; Pierre Housset; Melissa Pierre; Virginia Sauvaget; Denis Viglietti; Georges Deschenes; Renato C Monteiro; Laureline Berthelot
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

View more
  9 in total

1.  Towards better indications for kidney biopsy in adult IgA vasculitis: a clinical-laboratory and pathology correlation study.

Authors:  Valentin Maisons; Jean-Michel Halimi; Christelle Barbet; Évangeline Pillebout; Zhour El Ouafi; Eric Thervet; Benjamin Terrier; Yanis Ramdani; François Maillot; Alexandra Audemard-Verger
Journal:  J Nephrol       Date:  2022-08-13       Impact factor: 4.393

2.  Kidney biopsy diagnosis in childhood in the Norwegian Kidney Biopsy Registry and the long-term risk of kidney replacement therapy: a 25-year follow-up.

Authors:  Ann Christin Gjerstad; Rannveig Skrunes; Camilla Tøndel; Anders Åsberg; Sabine Leh; Claus Klingenberg; Henrik Døllner; Clara Hammarstrøm; Anna Kristina Bjerre
Journal:  Pediatr Nephrol       Date:  2022-08-22       Impact factor: 3.651

Review 3.  Findings on the Relationship Between Intestinal Microbiome and Vasculitis.

Authors:  Boyuan Sun; Xin He; Wen Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-06-27       Impact factor: 6.073

4.  Clinicopathologic comparisons of IgA nephropathy and IgA vasculitis nephropathy in children: a ten-year single-center experience.

Authors:  Qingxiao Su; Yuheng Liang; N A Wang; Zhiyan Dou; Zanhua Rong; Xue Zhao; B O Yu; Yuxue Wang; Xinliang Wang
Journal:  Turk J Med Sci       Date:  2021-08-16       Impact factor: 0.973

Review 5.  Pathogenesis of IgA Vasculitis: An Up-To-Date Review.

Authors:  Yan Song; Xiaohan Huang; Guizhen Yu; Jianjun Qiao; Jun Cheng; Jianyong Wu; Jianghua Chen
Journal:  Front Immunol       Date:  2021-11-09       Impact factor: 7.561

6.  Reactivation of IgA vasculitis following COVID-19 vaccination.

Authors:  James A Maye; Hsu Pheen Chong; Vivek Rajagopal; William Petchey
Journal:  BMJ Case Rep       Date:  2021-11-30

7.  Special Issue: New Insights into the Pathogenesis and Therapies of IgA Nephropathy.

Authors:  Hitoshi Suzuki; Jan Novak
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

8.  Efficacy and Safety of Glycosides of Tripterygium wilfordii Combined with Renin-Angiotensin System in the Treatment of IgA Nephropathy: A Systematic Review and Meta-Analysis.

Authors:  Ming Chen; Peiqing Zhang; Lianhua Li; Zhuo Yu; Na Liu; Lifan Wang
Journal:  Emerg Med Int       Date:  2022-09-30       Impact factor: 1.621

Review 9.  IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers.

Authors:  Liyun Xu; Yongzhen Li; Xiaochuan Wu
Journal:  Front Immunol       Date:  2022-10-03       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.